Management of Postoperative Pain After Cesarean Delivery Using Bridge Auricular Percutaneous Nerve Field Stimulator
Key facts
- Who runs it
- Inova Health Care Services
- Where
- Falls Church, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- Jun 2024
- Ended
- Sept 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Auricular percutaneous nerve field stimulator
- Sham auricular percutaneous nerve field stimulator
- Record updated
- 3 February 2025
- Why it stopped
- Funding
Who can take part
- Age
- 18 years to 55 years
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Female 18 years or older able to provide informed consent in English or Spanish
- Scheduled for cesarean delivery under neuraxial anesthesia
- Intact skin surface behind and around the ear at the site of electrode application
Who cannot take part
- Active drug abuse
- Previous history of sensitivity to compound benzoin tincture
- Subject is concurrently participating in another research study with an investigational drug or medical device that in the Investigator's opinion could impact subject safety or study results
- Subject with complex surgery or subject who may need more than a cesarean surgery with possible tubal sterilization procedure
- Cardiac pacemaker or implantable electronic devices
- Psoriasis vulgaris or other skin conditions precluding safe device application
- Chronic opioid user
- Severe chronic pain
- Hemophilia
- Hearing aid precluding proper placement of the device or removing which interferes with their hearing ability
- Subject with reasons to maintain an epidural beyond operative room
- Subject is deemed not suitable for the study at the discretion of the principal Investigator
Where in United States
- Inova Fairfax Medical CampusFalls Church, United States
About the trial
What the trial wants to find out
Post-cesarean section (CS) pain is commonly treated with acetaminophen, ibuprofen, and opioid medications as needed following delivery. About 300,000 women annually who were exposed to opioids after CS will go on to use opioids chronically. Reducing the quantity of post-CS opioids has been shown to decrease the amount of opioids used without compromising pain control. Bridge is a small device that sits on the outer ear and works similarly to a transcutaneous electrical nerve stimulation (TENS) unit to decrease pain sensation without medications. It has been shown to effectively reduce pain to decrease medication requirements after surgeries. This study aims to see if women receiving the Bridge device use need less pain medication than those without the device.
The 3 groups in the trial
- Bridge deviceExisting treatment, for comparison
Bridge device placed in post-anesthesia care unit (PACU) and worn until end-of-life of the device (at 5 days) in addition to standard of care pain medications as per institutional policy
Treatment: Auricular percutaneous nerve field stimulator
- Sham deviceSham treatment, for comparison
Sham (non-functional) Bridge device placed in post-anesthesia care unit (PACU) and worn until 5 days post-delivery in addition to standard of care pain medications as per institutional policy
Treatment: Sham auricular percutaneous nerve field stimulator
- Standard of careNo study treatment, for comparison
Standard of care pain medications only as per institutional policy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 3 February 2025